EQS Aktienübersicht
Equasens Société anonyme bietet IT-Lösungen für das Gesundheitswesen in Europa an. Mehr Details
Schneeflocken-Punktzahl | |
---|---|
Bewertung | 5/6 |
Künftiges Wachstum | 2/6 |
Vergangene Leistung | 2/6 |
Finanzielle Gesundheit | 6/6 |
Dividenden | 5/6 |
Belohnungen
Risikoanalyse
Bei unseren Risikoprüfungen wurden keine Risiken für EQS festgestellt.
Equasens Société anonyme Wettbewerber
Preisentwicklung & Leistung
Historische Aktienkurse | |
---|---|
Aktueller Aktienkurs | €41.60 |
52-Wochen-Hoch | €67.40 |
52-Wochen-Tief | €40.55 |
Beta | 0.89 |
11 Monat Veränderung | -16.38% |
3 Monate Veränderung | -11.68% |
1 Jahr Veränderung | -29.49% |
33 Jahre Veränderung | -51.63% |
5 Jahre Veränderung | -29.13% |
Veränderung seit IPO | 876.53% |
Aktuelle Nachrichten und Updates
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 03Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Recent updates
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 03Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Jun 07Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Aktionärsrenditen
EQS | FR Healthcare Services | FR Markt | |
---|---|---|---|
7D | -2.3% | 0.6% | -0.3% |
1Y | -29.5% | -11.3% | -4.2% |
Rendite im Vergleich zur Industrie: EQS unter dem Niveau der Branche French Healthcare Services , die im vergangenen Jahr eine Rendite von -11.3% erzielte.
Rendite vs. Markt: EQS hinter dem Markt French zurück, der im vergangenen Jahr eine Rendite von -4.2 erzielte.
Preisvolatilität
EQS volatility | |
---|---|
EQS Average Weekly Movement | 5.0% |
Healthcare Services Industry Average Movement | 5.9% |
Market Average Movement | 4.5% |
10% most volatile stocks in FR Market | 9.2% |
10% least volatile stocks in FR Market | 2.2% |
Stabiler Aktienkurs: EQS hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.
Volatilität im Zeitverlauf: EQSDie wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
Gegründet | Mitarbeiter | CEO | Website |
---|---|---|---|
1996 | 1,271 | Denis Supplisson | equasens.com |
Die Equasens Société anonyme bietet IT-Lösungen für das Gesundheitswesen in Europa an. Das Unternehmen bietet id. PATIENT, eine Business-Software; id.
Equasens Société anonyme's Grundlagenzusammenfassung
EQS grundlegende Statistiken | |
---|---|
Marktanteil | €625.30m |
Gewinn(TTM) | €42.25m |
Umsatz(TTM) | €215.16m |
14.8x
Kurs-Gewinn-Verhältnis2.9x
Kurs-Umsatz-VerhältnisIst EQS zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
EQS Gewinn- und Verlustrechnung (TTM) | |
---|---|
Einnahmen | €215.16m |
Kosten der Einnahmen | €151.30m |
Bruttogewinn | €63.86m |
Sonstige Ausgaben | €21.60m |
Umsatz | €42.25m |
Zuletzt gemeldete Gewinne
Jun 30, 2024
Datum des nächsten Gewinnberichts
k.A.
Gewinn per Aktie (EPS) | 2.81 |
Bruttomarge | 29.68% |
Nettogewinnspanne | 19.64% |
Schulden/Eigenkapital-Verhältnis | 24.0% |
Wie hat sich EQS auf lange Sicht entwickelt?
Historische Performance und Vergleiche